Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06578702 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Intermittent Triple Therapies in Real Life

Study acronym: ETRIVIE
StatusUnknown
PhaseNot specified
Started2024-02-21
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 29, 2024 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR. There is little data in real life, as shown in the meta-analysis of Parienti JJ et al. Currently this strategy is proposed by some teams in France, but is not recommended internationally. The research hypothesis is that intermittent treatment is an effective and safe option in a therapeutic lightening strategy in people living with HIV People living with HIV adults followed in Strasbourg who have benefited from intermittent treatment The expected results will consist of an improvement in knowledge on the efficacy and tolerance of this therapeutic strategy.
Trial Details
NCT Number NCT06578702
Lead Sponsor University Hospital, Strasbourg, France
Conditions HIV Infections
Enrollment 200 participants
Start Date 2024-02-21
Primary Completion 2025-02 (estimated)
Study Completion 2025-02-21 (estimated)
Updated on ClinicalTrials.gov 2024-08-29